GSK-207040

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H24N4O2
Molecular Weight	352.4302
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CNC(=O)C1=NC=C(OC2=CC=C3CCN(CCC3=C2)C4CCC4)N=C1

InChI

InChIKey=DGWKVXVCPCPOAK-UHFFFAOYSA-N

InChI=1S/C20H24N4O2/c1-21-20(25)18-12-23-19(13-22-18)26-17-6-5-14-7-9-24(16-3-2-4-16)10-8-15(14)11-17/h5-6,11-13,16H,2-4,7-10H2,1H3,(H,21,25)

HIDE SMILES / InChI

Molecular Formula	C20H24N4O2
Molecular Weight	352.4302
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:33:25 GMT 2025` Edited by `admin` on `Mon Mar 31 23:33:25 GMT 2025`
Record UNII	3SW22QPG5V
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

2-PYRAZINECARBOXAMIDE, 5-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-7-YL)OXY)-N-METHYL-

Preferred Name

English

GSK-207040

Code

English

GSK207040

Code

English

5-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-7-YL)OXY)-N-METHYLPYRAZINE-2-CARBOXAMIDE

Systematic Name

English

PYRAZINECARBOXAMIDE, 5-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-7-YL)OXY)-N-METHYL-

Systematic Name

English

Code System Code Type Description

FDA UNII

3SW22QPG5V

Created by admin on Mon Mar 31 23:33:25 GMT 2025 , Edited by admin on Mon Mar 31 23:33:25 GMT 2025

PRIMARY

PUBCHEM

10473209

Created by admin on Mon Mar 31 23:33:25 GMT 2025 , Edited by admin on Mon Mar 31 23:33:25 GMT 2025

PRIMARY

CAS

720690-77-7

Created by admin on Mon Mar 31 23:33:25 GMT 2025 , Edited by admin on Mon Mar 31 23:33:25 GMT 2025

PRIMARY

Related Record Type Details


					3SW22QPG5V

GSK-207040

ACTIVE MOIETY